Nurse Practitioner, Family · Richmond, VA
NPI
1417208984
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5875 Bremo Rd, Suite G-11
Richmond, VA, 23226
Phone (804) 287-7804
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,079 services
Medicare patients, 2024
131
Average age 75
Drug cost, 2024
$3.8M
1,029 prescriptions
Company payments, 2025
$301
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan T Cannon was code 99215 (office e&m - established), 507 times for 92 patients. In total Megan T Cannon billed 1,079 services in 7 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 507 | 92 | $92.69 | $47K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 487 | 104 | $10.64 | $5,181 |
| 99214 Office E&M - Established | Office | 68 | 51 | $60.73 | $4,130 |
By year: 2023 $1,222 for 19 services; 2024 $57K for 1,079 services.
Medicare prescription drug claims, 2024
In 2024, the drug Megan T Cannon prescribed most often to Medicare patients was Eliquis (Apixaban), with 55 prescriptions and refills. In total Megan T Cannon wrote 1,029 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 55 | 87 | 16 | $49K |
| Oxycodone Hcl Generic | 51 | 51 | 12 | $1,359 |
| Calquence Acalabrutinib Maleate | 44 | 44 | Under 11 | $662K |
| Prednisone Generic | 40 | 48 | 12 | $142 |
| Hydroxyurea Generic | 36 | 89 | 15 | $990 |
| Cabometyx Cabozantinib S-Malate | 32 | 32 | Under 11 | $786K |
| Dexamethasone Generic | 31 | 35 | 20 | $627 |
| Lenalidomide Generic | 31 | 31 | Under 11 | $461K |
| Prochlorperazine Maleate Generic | 28 | 28 | 16 | $546 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 27 | 27 | 19 | $334 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 25 | 25 | Under 11 | $397 |
| Ondansetron Odt Ondansetron | 24 | 24 | 11 | $497 |
| Klor-Con M20 Potassium Chloride | 23 | 48 | Under 11 | $303 |
| Anastrozole Generic | 22 | 61 | 11 | $528 |
| Alecensa Alectinib Hcl | 22 | 22 | Under 11 | $289K |
Brand drugs: - claims; generic drugs: 710 claims; opioid claims: 87.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megan T Cannon $301 ($301 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $127.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.